GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CFO Buys Highlight: Casual Male Retail Group Inc., Vestin Realty Mortgage II Inc., Exelixis Inc., Aastrom Biosciences Inc., Dyax Corp.

August 28, 2010 | About:
guruek

gurujk

5 followers
According to GuruFocus Insider Data, the largest CFO buys during the past week Casual Male Retail Group Inc., Vestin Realty Mortgage II Inc., Exelixis Inc., Aastrom Biosciences Inc., and Dyax Corp.

EVP, COO and CFO of Casual Male Retail Group Inc. (CMRG) Dennis R Hernreich bought 50,700 shares on 08/24/2010 at an average price of $3.07. Casual Male Retail Group, Inc. operates Casual Male Big & Tall stores, Levi's Outlet by Designs and Dockers Outlet by Designs stores, Candies Outlet stores and Ecko Unltd. Casual Male Retail Group Inc. has a market cap of $158.8 million; its shares were traded at around $3.33 with a P/E ratio of 12.8 and P/S ratio of 0.4.

Casual Male Retail Group, Inc. reported operating results for the second quarter ended July 31, 2010. Net income increased 56% to $5.6 million, or $0.12 per diluted share, from $3.6 million, or $0.09 per diluted share. For the second quarter of fiscal 2010, comparable sales increased 0.8% while total sales declined 1.0% to $97.3 million as compared to the prior year's second quarter.

CMRG is in the portfolios of Chuck Royce of Royce& Associates, George Soros of Soros Fund Management LLC, Jim Simons of Renaissance Technologies LLC.

EVP, COO and CFO Dennis R Hernreich and Director, 10% Owner Seymour Holtzman bought shares of CMRG stock.

Vestin Realty Mortgage II Inc. (VRTB): President, CEO & CFO Michael V Shustek Bought 81,458 Shares

President, CEO & CFO of Vestin Realty Mortgage II Inc. (VRTB) Michael V Shustek bought 81,458 shares during the past week at an average price of $1.62. Vestin Realty Mortgage II, Inc., a real estate investment trust, invests in short-term loans secured by real estate through deeds of trust or mortgages. Vestin Realty Mortgage Ii Inc. has a market cap of $23.3 million; its shares were traded at around $1.71 with and P/S ratio of 3.5.

Vestin Realty Mortgage II Inc. announced results of operations for the three and six months ended June 30, 2010. The Company reported a net loss of approximately $6.2 million or ($0.45) per share and $8.7 million or ($0.64) per share, respectively, for the three and six months ended June 30, 2010 compared with a net loss of approximately $14.5 million or ($1.05) per share and $20.9 million or ($1.52) per share, respectively, for the three and six months ended June 30, 2009.

VRTB is in the portfolios of Chuck Royce of Royce& Associates.

President, CEO & Interim CFO Michael V Shustek bought shares of VRTB stock.

Exelixis Inc. (EXEL): EVP & CFO Frank Karbe Bought 16,500 Shares

EVP & CFO of Exelixis Inc. (EXEL) Frank Karbe bought 16,500 shares on 08/24/2010 at an average price of $2.98. Exelixis Inc. is a leader in the fields of model system genetics andcomparative genomics. Exelixis Inc. has a market cap of $353.8 million; its shares were traded at around $3.26 with and P/S ratio of 2.4. Exelixis Inc. had an annual average earning growth of 2.1% over the past 10 years. GuruFocus rated Exelixis Inc. the business predictability rank of 1-star.

Exelixis, Inc. reported financial results for the second quarter ended June 30, 2010. Revenues for the quarter ended June 30, 2010 were $47.6 million compared to $27.4 million for the comparable period in 2009. Net loss attributable to Exelixis, Inc. for the quarter ended June 30, 2010 was $22.6 million, or $0.21 per share, compared to $44.8 million, or $0.42 per share, for the comparable period in 2009.

EXEL is in the portfolios of Carl Icahn of Icahn Capital Management LP, Chuck Royce of Royce& Associates, Bruce Kovner of Caxton Associates, Jim Simons of Renaissance Technologies LLC.

President & CEO Michael Morrissey, EVP & CFO Frank Karbe, Director Stelios Papadopoulos bought shares EXEL stock.

Aastrom Biosciences Inc. (ASTM): CFO Scott Durbin Bought 16,463 Shares

CFO of Aastrom Biosciences Inc. (ASTM) Scott Durbin bought 16,463 shares on 08/26/2010 at an average price of $1.45. Aastrom Biosciences, Inc. develops autologous cell products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell technology. Aastrom Biosciences Inc. has a market cap of $39.6 million; its shares were traded at around $1.4 with and P/S ratio of 444.5.

Aastrom Biosciences, Inc. reported operating results for the fourth quarter and fiscal year ended June 30, 2010. As of June 30, 2010, the company had a total of $19.1 million in cash, cash equivalents and short term investments, compared to $17.0 million in cash and equivalents at June 30, 2009. Net loss for the quarter ended June 30, 2010 was $5.1 million, or $0.18 per share, compared to a net loss of $4.0 million, or $0.20 per share, for the same period in fiscal year 2009.

CEO, President, CFO & Director Timothy M Mayleben, CFO Scott Durbin, and CEO, President, CFO & Director Timothy M Mayleben bought shares of ASTM stock.

Dyax Corp. (DYAX): EVP & CFO George V Migausky Bought 12,000 Shares

EVP & CFO of Dyax Corp. (DYAX) George V Migausky bought 12,000 shares on 08/24/2010 at an average price of $2.15. Dyax Corp is a biopharmaceutical company that has developed and patented a method that is used to identify a broad range of compounds with potential for the treatment and diagnosis of diseases. Dyax Corp. has a market cap of $228.5 million; its shares were traded at around $2.34 with and P/S ratio of 10.5. Dyax Corp. had an annual average earning growth of 0.6% over the past 5 years.

Dyax Corp. announced financial results for the second quarter ended June 30, 2010. Total revenues for the second quarter ended June 30, 2010 increased to $15.1 million, as compared to $4.8 million for the same quarter in 2009. Total revenues for the six months ended June 30, 2010 increased to $35.2 million from $10.8 million in the comparable period in 2009. For the quarter ended June 30, 2010, Dyax reported a net loss of $5.3 million or $0.05 per share, as compared to a net loss of $14.4 million or $0.23 per share for the comparable quarter in 2009. For the six months ended June 30, 2010, Dyax reported net loss was $4.3 million or $0.05 per share, as compared to $39.3 million or $0.62 per share for the comparable period in 2009.

DYAX is in the portfolios of Chuck Royce of Royce& Associates, PRIMECAP Management, Louis Moore Bacon of Moore Capital Management, LP.

EVP & CFO George V Migausky and EVP Corporate Development & GC Ivana Magovcevic bought shares of DYAX stock.

For the complete list of stocks that bought by their CFOs, go to: Insider Buys.


Rating: 3.6/5 (5 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK